ANTI-INFLAMMATORY AND ANALGESIC PROPERTIES OF CARALLUMA FIMBRIATA: A COMPREHENSIVE STUDY
Main Article Content
Keywords
.
Abstract
This comprehensive preclinical investigation explores the anti-inflammatory, analgesic, and anxiolytic properties of Caralluma fimbriata extract using validated animal models. The study systematically examines the therapeutic potential of the methanolic extract administered at two graded doses—100 mg/kg and 200 mg/kg—benchmarking its effects against standard pharmacological agents known for their efficacy in each respective domain. To evaluate the anti-inflammatory efficacy, the carrageenan-induced paw edema model was employed, while nociceptive response was measured using the hot plate test. Additionally, the elevated plus-maze paradigm was utilized to assess the anxiolytic profile of the extract. The results indicate that Caralluma fimbriata exhibits pronounced, dose-dependent anti-inflammatory activity, as evidenced by significant attenuation of paw swelling. Concurrently, the extract elicited notable antinociceptive effects, suggesting its potential utility in pain management. Furthermore, behavioral analyses revealed a substantial reduction in anxiety-like symptoms, highlighting its anxiolytic capacity. Phytochemical screening of the extract revealed a rich repertoire of bioactive constituents, prominently including pregnane glycosides, flavonoids, saponins, and phenolic compounds. These phytoconstituents are believed to act synergistically through multiple pharmacodynamic pathways, including the inhibition of cyclooxygenase enzymes, modulation of inflammatory mediators, suppression of oxidative stress, and interaction with central neurotransmitter systems. Collectively, the findings of this study underscore the potential of Caralluma fimbriata as a multifaceted natural therapeutic agent. Its ability to alleviate inflammation, mitigate pain, and reduce anxiety symptoms presents a compelling case for its further development as a phytopharmaceutical intervention. Given its traditional use and favorable preliminary safety profile, Caralluma fimbriata may offer a promising alternative or adjunct to conventional therapies for managing inflammatory disorders, nociceptive pain, and anxiety-related conditions.
References
2. Balfour, J. E. (2002). Painful conditions in older adults with dementia: Are analgesics and psychotropics inappropriately prescribed? Simon Fraser University, Canada, pp. 6–18.
3. Ban, T. A., et al. (1981). Therapeutic monograph on anxiolytic-sedative drugs. CMA Journal, 124, 1439–1446.
4. Bowie, A. G., Moynagh, P. N., & O’Neill, L. A. (1997). Lipid peroxidation is involved in the activation of NF-κB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Journal of Biological Chemistry, 272, 25941–25950.
5. Burdock, G. A., & Carabin, I. G. (2009). Safety assessment of coriander (Coriandrum sativum L.) essential oil as a food ingredient. Food and Chemical Toxicology, 47, 22–34.
6. Catherine, B., & Guy, G. (2001). Measuring normal and pathological anxiety-like behavior in mice: a review. Behavioural Brain Research, 125, 141–149.
7. Crawley, J., & Goodwin, F. K. (1980). Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacology Biochemistry and Behavior, 13, 167–170.
8. Emamghoreishi, M., Khasaki, M., & Aazam, M. F. (2005). Coriandrum sativum: Evaluation of its anxiolytic effect in the elevated plus-maze. Journal of Ethnopharmacology, 96, 365–370.
9. Hwa, Y. C., Jeong, H. P., Jin, T. H., Hwan, S. Y., Sukjil, S., Bang, Y. H., et al. (2005). Anxiolytic-like effects of ginsenosides on the elevated plus-maze model. Biological & Pharmaceutical Bulletin, 28(9), 1621–1625.
10. Kamalakkannan, S., Rajendran, R., Venkatesh, R. V., Clayton, P., & Akbarsha, M. A. (2011). Antiobesogenic and antiatherosclerotic properties of Caralluma fimbriata extract. Journal of Nutrition and Metabolism, 2011, 1-7.
11. Kumar, V., Cotran, R. S., & Robbins, S. L. (2003). Robbins Basic Pathology. Philadelphia: Saunders.
12. Latha, S., Rajaram, K., & Suresh Kumar, P. (2014). Hepatoprotective and antidiabetic effect of methanol extract of Caralluma fimbriata in streptatozocin induced diabetic albino rats. International Journal of Pharmacy and Pharmaceutical Sciences, 6, 665-668.
13. Li, Q., & Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nature Reviews Immunology, 2, 725–734.
14. McCaffery, M. (1972). Nursing management of the patient with pain. Philadelphia: Lippincott.
15. Naingade, S. S., Jadhav, A. S., & Surve, S. B. (2013). Caralluma fimbriata: An overview. International Journal of Pharmaceutical Research and Bio-Science, 2(1), 322-326.
16. Nathan, C. (2002). Points of control in inflammation. Nature, 420, 846–852.
17. Posadas, I., Terencio, M. C., Guillen, I., Ferrandiz, M. L., Coloma, J., Paya, M., et al. (2000). Co-regulation between cyclooxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn Schmiedebergs Archives of Pharmacology, 361, 98–106.
18. Rang, H. P., Dale, M. M., Ritter, J. M., & Flower, R. J. (2007). Rang and Dale’s pharmacology (6th ed., p. 588). Churchill Livingstone Elsevier.
19. Salvemini, D., Mazzon, E., Dugo, L., & Riley, D. P. (2001). Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic. British Journal of Pharmacology, 132, 815–827.
20. Shen, S. C., Lee, W. R., Lin, H. Y., Huang, H. C., Ko, C. H., Yang, L. L., & Chen, Y. C. (2002). In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production. European Journal of Pharmacology, 446, 187–194.
21. Thakur, V. D., & Mengi, S. A. (2003). Neuropharmacological profile of Eclipta alba (Linn.) Hassk. Journal of Ethnopharmacology, 85, 514–519.
22. Woolf, C. J., & Mannion, R. J. (1999). Neuropathic pain: Etiology, symptoms, mechanisms, and management. Lancet, 353, 1959–1964.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Indu Saini
M. Pharmacy Student, Faculty of Pharmaceutical Sciences, Motherhood University, Dehradun Road, Karoundi village, Bhagwanpur post, Roorkee Tehsil, Haridwar Distt.
Kokkula Pavan Kumar
Associate Professor, Faculty of Pharmaceutical Sciences, Motherhood University, Dehradun Road, Karoundi village, Bhagwanpur post, Roorkee Tehsil, Haridwar Distt., Uttarakhand, India 247661.
K. Ashok Kumar
Professor, Faculty of Pharmaceutical Sciences, Motherhood University, Dehradun Road, Karoundi village, Bhagwanpur post, Roorkee Tehsil, Haridwar Distt., Uttarakhand, India 247661.